Combined use of insulin and endothelin-1 causes decrease of protein expression of β-subunit of insulin receptor, insulin receptor substrate-1, and insulin-stimulated glucose uptake in rat adipocytes

Journal of Cellular Biochemistry

Volumn 78, Issue 2, 2000, Pages 231-240

  Shih, Kuang Chung ^a,b   Kwok, Ching Fai ^c   Ho, Low Tone ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b Division of General Surgery Department of Surgery Taoyuan Military General Hospital   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adipocyte; Endothelin 1; Insulin receptor; Insulin receptor substrate 1; Insulin resistance

Indexed keywords

ENDOTHELIN 1; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BETA CHAIN; CONTROLLED STUDY; GENE REPRESSION; GLUCOSE TRANSPORT; HORMONAL REGULATION; HORMONE ACTION; INSULIN BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; DRUG INTERACTIONS; ENDOTHELIN-1; GLUCOSE; INSULIN; KINETICS; MALE; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN;

ANIMALIA;

EID: 0034046486     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000801)78:2<231::AID-JCB6>3.0.CO;2-O     Document Type: Article

References (47)

1. Backer JM, Myers MG Jr, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, White MF. 1992. Phosphatidylinositol 3-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479.
2. Baillie GM, Sherer JT, Weart CW. 1998. Insulin and coronary artery disease: is syndrome X the unifying hypothesis? Ann Pharmacother 32:233-247.
3. Berger J, Biswas C, Vicario PP, Strout HV, Saperstein R, Pilch PF. 1989. Decreased expression of the insulinresponsive glucose transporter in diabetes and fasting. Nature 340:70-72.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14:4902-4911.
6. Chou YC, Perng JC, Juan CC, Jang SY, Kwok CF, Chen WL, Fong JC, Ho LT. 1994. Endothelin-1 inhibits insulin-stimulated glucose uptake in isolated rat adipocytes. Biochem Biophys Res Commun 202:688-693.
7. Chung J, Grammer TC, Lemon KP, Kazlauskas A, Blenis J. 1994. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370:71-75.
8. Clerk A, Bogoyevitch MA, Anderson MB, Sugden PH. 1994. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem 269:32848-32857.
9. Desbois C, Capeau J, Hainault I, Wicek D, Reynet C, Veissiere D, Caron M, Picard J, Guerre-Millo M, Cherqui G. 1992. Differential role of insulin receptor autophosphorylation sites 1162 and 1163 in the long-term insulin stimulation of glucose transport, glycogenesis, and protein synthesis. J Biol Chem 267:13488-13497.
10. Di Girolamo M, Mendlinger S, Fertig JW. 1971. A simple method to determine fat cell size and number in four mammalian species. Am J Physiol 221:850-858.
11. Eckel J, Gerlach-Eskuchen E, Reinauer H. 1990. G-protein-mediated regulation of the insulin-responsive glucose transporter in isolated cardiac myocytes. Biochem J 272:691-696.
12. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. 1987. Insulin resistance in essential hypertension. N Engl J Med 317:350-357.
13. Ferri C, Carlomagno A, Coassin S, Baldoncini R, Cassone Faldetta MR, Laurenti O, Properzi G, Santucci A, De Mattia G. 1995. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care 18:226-233.
14. Folli F, Saad MJ, Backer JM, Kahn CR. 1992. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 267: 22171-22177.
15. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736.
16. Garvey WT, Olefsky JM, Matthaei S, Marshall S. 1987. Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem 262:189-197.
17. Gillespie PG, Hudspeth AJ. 1991. Chemiluminescence detection of proteins from single cells. Proc Natl Acad Sci USA 88:2563-2567.
18. Haring H, Obermaier-Kusser B. 1989. Insulin receptor kinase defects in insulin-resistant tissues and their role in the pathogenesis of NIDDM. Diabetes Metab Rev 5:431-441.
19. Huang YJ, Fang VS, Juan CC, Chou YC, Kowk CF, Ho LT. 1997. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 46:1252-1258.
20. Jiang ZY, Zhou QL, Chatterjee A, Feener EP, Myers MG Jr, White MF, King GL. 1999. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 48: 1120-1130.
21. Juan CC, Fang VS, Huang YJ, Kwok CF, Hsu YP, Ho LT. 1996. Endothelin-1 induces insulin resistance in conscious rats. Biochem Biophys Res Commun 227:694-699.
22. Juan CC, Fang VS, Kwok CF, Perng JC, Chou YC, Ho LT. 1999. Exogenous hyperinsulinemia causes insulin resistance, hyperendothelinemia, and subsequent hypertension in rats. Metabolism 48:465-471.
23. Kahn CR. 1994. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084.
24. Kahn CR. 1995. Diabetes. Causes of insulin resistance. Nature 373:384-385.
25. Kelly KL, Ruderman NB. 1993. Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem 268: 4391-4398.
26. Kozka IJ, Clark AE, Holman GD. 1991. Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes. J Biol Chem 266:11726-11731.
27. A receptors. Metabolism 47:1468-1471.
28. Li J, DeFea K, Roth RA. 1999. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem 274:9351-9356.
29. Mendez R, Myers MG Jr, White MF, Rhoads RE. 1996. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol Cell Biol 16:2857-2864.
30. Olefsky JM, Kolterman OG. 1981. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med 70:151-168.
31. Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G. 1997. Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand 161:211-220.
32. Pedersen O, Hjollund E, Beck-Nielsen H, Lindskov HO, Sonne O, Gliemann J. 1981. Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes. Diabetologia 20:636-641.
33. Reynet C, Caron M, Magre J, Cherqui G, Clauser E, Picard J, Capeau J. 1990. Mutation of tyrosine residues 1162 and 1163 of the insulin receptor affects hormone and receptor internalization. Mol Endocrinol 4:304-311.
34. Rice KM, Turnbow MA, Garner CW. 1993. Insulin stimulates degradation of IRS-1 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 190:961-967.
35. Rodbell M. 1966. The metabolism of isolated fat cell. IV. Regulation of release of protein by lipolytic hormones and insulin. J Biol Chem 241:3909-3917.
36. Roden M, Vierhapper H, Liener K, Waldhausl W. 1992. Endothelin-1-stimulated glucose production in vitro in the isolated perfused rat liver. Metabolism 41:290-295.
37. Rosen OM. 1987. After insulin binds. Science 237:1452-1458.
38. Shepherd PR, Nave BT, Siddle K. 1995. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem J 305:25-28.
39. Thies RS, Molina JM, Ciaraldi TP, Freidenberg GR, Olefsky JM. 1990. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects. Diabetes 39:250-259.
40. Traxinger RR, Marshall S. 1989. Recovery of maximal insulin responsiveness and insulin sensitivity after induction of insulin resistance in primary cultured adipocytes. J Biol Chem 264:8156-8163.
41. Traxinger RR, Marshall S. 1990. Glucose regulation of insulin receptor affinity in primary cultured adipocytes. J Biol Chem 265:18879-18883.
42. White MF, Kahn CR. 1994. The insulin signaling system. J Biol Chem 269:1-4.
43. Wu-Wong JR, Berg CE, Wang J, Chiou WJ, Fissel B. 1999. Endothelin stimulates glucose uptake and GLUT4 translocation via activation of endothelin ETA receptor in 3T3-L1 adipocytes. J Biol Chem 274:8103-8110.
44. Yamauchi K, Milarski KL, Saltiel AR, Pessin JE. 1995. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci USA 92: 664-668.
45. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415.
46. Yang XY, Fekete Z, Gardner J, Benevenia J, Aviv A. 1994. Endothelin mobilizes calcium and enhances glucose uptake in cultured human skeletal myoblasts and L6 myotubes. Hypertension 23:1075-1081.
47. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M. 1989. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706.